Warrants (Details) |
3 Months Ended |
|---|---|
|
Apr. 30, 2021
$ / shares
shares
| |
| Warrants | |
| Warrants outstanding shares, Beginning | shares | 2,675,000 |
| Exercised, shares | shares | 100,000 |
| Granted, shares | shares | 1,100,000 |
| Warrants outstanding shares, Ending | shares | 3,675,000 |
| Warrants outstanding weighted average conversion price, Beginning | $ / shares | $ 1.00 |
| weighted average conversion price, Exercised | $ / shares | 1.00 |
| Weighted average conversion price, Granted | $ / shares | 2.21 |
| Warrants outstanding weighted average conversion price, Ending | $ / shares | $ 1.36 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Change in the weighted average exercise price of options outstanding. No definition available.
|